Growing awareness of nosocomial infections and their multi-level effects will drive the European surgical infection control market. At the same time, ongoing initiatives to implement standardized regulations on a pan-European basis will ensure consistency in products and prices across Europe.
Frost & Sullivan (medicaldevices.frost.com) finds that the European Surgical Infection Control Market earned revenues of $159.4 million in 2006 and estimates this to reach $244.1 in 2013.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Surgical Infection Control in Europe then send an e-mail to Danielle White Corporate Communications at dwhite[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information via email upon receipt of the above information.
“Market growth will be spurred by the importance given to awareness campaigns about nosocomial infections across Europe,” notes Frost & Sullivan Research Associate Sabita Ramachandran. “Rising awareness in public health and political arenas as well as among the general public will positively influence market expansion.”
In addition to limited awareness of nosocomial infections, a brand-oriented landscape, the lack of uniform pan-European regulations and the need to maximise product efficacy are posing challenges to market growth.
At present, global and pan-European brands dominate the competitive landscape. However, market penetration will not be very easy to undertake due to the strong presence of Tier I participants. Product classification also varies across some countries due to the lack of uniform pan-European regulations, thereby making it harder for smaller companies to license their products across Europe.
“In this highly competitive market, it is important to distinguish offerings based on factors of maximum product efficacy,” advises Ms. Ramachandran. “Effective and accelerated antimicrobial action of products in combination with superior after-sales services will help companies achieve success.”
Surgical Infection Control in Europe is part of the Medical Devices Subscription which also includes research in the following markets: Global Lancets Market, European Markets for Wound Closure, and European Markets for Wound Debridement, European Orthopaedic Implants Market and Introduction to Healthcare and Medical Devices in Poland. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.